357952-86-4

Basic information

• Product Name: (S)-(+)-1-(4-Fluorophenyl)-2-(p-tolylsulfonyloxy)ethanol
• Synonyms: (S)-(+)-1-(4-Fluorophenyl)-2-(p-tolylsulfonyloxy)ethanol
• CAS NO: 357952-86-4
• Molecular Weight: 310.346
• Mol File: 357952-86-4.mol

Chemical Properties

• CAS DataBase Reference: (S)-(+)-1-(4-Fluorophenyl)-2-(p-tolylsulfonyloxy)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-(+)-1-(4-Fluorophenyl)-2-(p-tolylsulfonyloxy)ethanol(357952-86-4)
• EPA Substance Registry System: (S)-(+)-1-(4-Fluorophenyl)-2-(p-tolylsulfonyloxy)ethanol(357952-86-4)

Safety Data

• Hazardous Substances Data: 357952-86-4(Hazardous Substances Data)

Upstream product

• 104-15-4 toluene-4-sulfonic acid 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 27126-76-7 [hydroxy(tosyloxy)iodo]benzene 
• 357952-79-5 1-(4-fluorophenyl)-2-(p-tolylsulfonyloxy)ethanone 

Downstream Products

• 473552-27-1 (S)-(+)-2-amino-1-(p-fluorophenyl)ethanol 
• 297765-48-1 (1S)-2-azido-1-(4-fluorophenyl)ethan-1-ol 
• 18511-62-1 (2S)-2-(4-fluorophenyl)oxirane 

Relevant articles and documents

Diastereoselective Alkene Hydroesterification Enabling the Synthesis of Chiral Fused Bicyclic Lactones

Palladium-catalysed diastereoselective hydroesterification of alkenes assisted by the coordinative hydroxyl group in the substrate afforded a variety of chiral γ-butyrolactones bearing two stereocenters. Employing the carbonylation-lactonization products as the key intermediates, the route from the alkenes with single chiral center to chiral THF-fused bicyclic γ-lactones containing three stereocenters was developed.

COMPOUNDS WHICH INHIBIT THE GLYCINE TRANSPORTER AND USES THEREOF

Compounds of formula (I) and salts and solvates are provided wherein R2 is selected from phenyl substituted with n R1 groups, and pyridyl substituted with n R1 groups; n = 0, 1 or 2; each R1 is independently selected from the group consisting of halo, C1-4alkyl, C1-4alkoxy, haloC1-4alkyl, haloC1-4alkoxy and cyano; R3 is selected from hydrogen and C1-2 alkyl; R4 is selected from the group consisting of ethyl, n- propyl, i-propyl, n-butyl, i-butyl and t-butyl; or R3 and R4 together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocyclic ring optionally substituted with one or more groups X; each X is independently selected from the group consisting of C1-4alkyl, and haloC1-4alkyl; R12 is selected from the group consisting of hydrogen, fluoro, chloro, bromo, methyl and methylthio; R13 is selected from hydrogen, chloro and trifluoromethyl; R14 is selected from hydrogen, trifluoromethyl and chloro; R15 is selected from hydrogen, chloro and trifluoromethyl; R16 is selected from hydrogen, methyl, fluoro and chloro; R12, R13, R14, R15 and R16 not all simultaneously being hydrogen. Processes for the preparation and uses of the compounds as medicaments for treating disorders such as psychoses, dementia or attention deficit disorder are also disclosed.

Convenient synthesis of optically active 1,2-diol monosulfonates and terminal epoxides via oxazaborolidine-catalyzed asymmetric borane reduction of α-sulfonyloxy ketones

A very convenient asymmetric synthesis of 1,2-diol monosulfonates and terminal epoxides with high optical purity via oxazaborolidine-catalyzed asymmetric borane reduction of α-sulfonyloxy ketones using N-ethyl-N-isopropylaniline-borane complex as borane carrier has been developed.